These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34686105)

  • 1. The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.
    Gusho CA; Weiss MC; Lee L; Gitelis S; Blank AT; Wang D; Batus M
    Acta Oncol; 2022 Jan; 61(1):38-44. PubMed ID: 34686105
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics.
    Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL
    Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.
    Cote GM; He J; Choy E
    Oncologist; 2018 Feb; 23(2):234-242. PubMed ID: 28860410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcoma.
    Lewin J; Garg S; Lau BY; Dickson BC; Traub F; Gokgoz N; Griffin AM; Ferguson PC; Andrulis IL; Sim HW; Kamel-Reid S; Stockley TL; Siu LL; Wunder JS; Razak ARA
    Int J Cancer; 2018 Jan; 142(1):57-65. PubMed ID: 28891048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas.
    Kokkali S; Georgaki E; Mandrakis G; Valverde C; Theocharis S
    Cells; 2023 Nov; 12(22):. PubMed ID: 37998367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
    Italiano A; Dinart D; Soubeyran I; Bellera C; Espérou H; Delmas C; Mercier N; Albert S; Poignie L; Boland A; Bourdon A; Geneste D; Cavaille Q; Laizet Y; Khalifa E; Auzanneau C; Squiban B; Truffaux N; Olaso R; Gerber Z; Wallet C; Bénard A; Blay JY; Laurent-Puig P; Deleuze JF; Lucchesi C; Mathoulin-Pelissier S;
    BMC Cancer; 2021 Nov; 21(1):1180. PubMed ID: 34740331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There Value in Molecular Profiling of Soft-Tissue Sarcoma?
    Italiano A
    Curr Treat Options Oncol; 2018 Dec; 19(12):78. PubMed ID: 30523434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
    Szurian K; Kashofer K; Liegl-Atzwanger B
    Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
    Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
    Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next Generation Sequencing Reveals Pathogenic and Actionable Genetic Alterations of Soft Tissue Sarcoma in Chinese Patients: A Single Center Experience.
    Jin G; Wang C; Jia D; Qian W; Yin C; Wang D; Yang Q; Li T; Zheng A
    Technol Cancer Res Treat; 2021; 20():15330338211068964. PubMed ID: 34939467
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
    Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
    Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Utility of Genomic Profiling in the Treatment of Advanced Sarcomas: A Single-Center Experience.
    Boddu S; Walko CM; Bienasz S; Bui MM; Henderson-Jackson E; Naghavi AO; Mullinax JE; Joyce DM; Binitie O; Letson GD; Gonzalez RJ; Reed DR; Druta M; Brohl AS
    JCO Precis Oncol; 2018 Nov; 2():1-8. PubMed ID: 35135155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel fusion sarcomas including targetable NTRK and ALK.
    Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
    Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study.
    Antoniotti C; Korn WM; Marmorino F; Rossini D; Lonardi S; Masi G; Randon G; Conca V; Boccaccino A; Tomasello G; Passardi A; Swensen J; Ugolini C; Oberley M; Tamburini E; Casagrande M; Domenyuk V; Fontanini G; Giordano M; Abraham J; Spetzler D; Falcone A; Lenz HJ; Cremolini C
    Eur J Cancer; 2021 Sep; 155():73-84. PubMed ID: 34365081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience.
    Tirrò E; Martorana F; Micale G; Inzerilli N; Carciotto R; Romano C; Longhitano C; Motta G; Lanzafame K; Stella S; Massimino M; Vitale SR; Salvatorelli L; Magro G; Manzella L; Vigneri P
    Pathol Res Pract; 2022 Apr; 232():153820. PubMed ID: 35240549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Profiling of Sarcomas: A Promising Weapon in the Therapeutic Arsenal.
    Lopes-Brás R; Lopez-Presa D; Esperança-Martins M; Melo-Alvim C; Gallego L; Costa L; Fernandes I
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing for the management of sarcomas with no known driver mutations.
    Vyse S; Thway K; Huang PH; Jones RL
    Curr Opin Oncol; 2021 Jul; 33(4):315-322. PubMed ID: 33927108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The landscape of gene mutations and clinical significance of tumor mutation burden in patients with soft tissue sarcoma who underwent surgical resection and received conventional adjuvant therapy.
    Xu LB; Zhao ZG; Xu SF; Zhang XX; Liu T; Jing CY; Zhang SG; Yu SJ
    Int J Biol Markers; 2020 Sep; 35(3):14-22. PubMed ID: 32520634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.